About
Celularity Inc (NASDAQ:CELU) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Celularity Announces Closing of Transaction with NexGel
Apr 17 2026
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
Mar 12 2026
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities
Mar 10 2026
Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy
Feb 10 2026
Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses
Financials
Revenue
$40.58 M
Market Cap
$40.37 M
EPS
-3.33
Google Übersetzer